Clinical Trial Update: Clinical Study of 177Lu-CTR-FAPI In the Treatment of Patients With Advanced, Metastatic Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

This entry describes an early-phase (Phase 1) clinical trial evaluating Lutetium-177 labeled CTR-FAPI for pancreatic cancer and other advanced, metastatic solid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 177Lu-CTR-FAPI

Snippet

Sponsor: Yan Xing | Conditions: Pancreatic Cancer | EARLY_Phase 1 | Status: RECRUITING